http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1419256-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a717ea5b2ac78ac329ab3a9659d834d2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D499-54
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-43
filingDate 1972-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1975-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1419256-A
titleOfInvention Penicillins and processes for the preparation of penicillins
abstract 1419256 6 [(1-Amino-cycloalkyl)actamido]- penicillanic acids AMERICAN HOME PRO DUCTS CORP 13 Dec 1972 [16 Dec 1971] 57404/72 Heading C2C New penicillins of the general formula wherein R and R<SP>1</SP> are each H or C 1 -C 3 alkyl, Y is -CH 2 -, n is an integer from 1 to 5 and Z is an amino group optionally protected with a removable blocking group, are prepared by reacting a compound of Formula III wherein Z is an amino group or a group convertible thereto, an azido group or a nitro group with 6-aminopenicillanic acid or a functional derivative thereof followed, if necessary, by conversion of the group Z to an amino group by conventional methods. Alternatively, an N-carboxy amino acid anhydride of general formula or a 1-aminocycloalkaneacetic acid chloride hydrochloride of general formula where n, R, R<SP>1</SP> and Y have the above meanings may be reacted with the penicillanic acid compound which, in either case, may be a silyl derivative, a phosphorylated derivative or a 6-aminopenicillanamide in which the amide group is -CONXY wherein X and Y are electron-withdrawing groups or form, together with the N atom, a cyclic electron-withdrawing group followed by appropriate reactions to regenerate the carboxylic acid group of the penicillanic acid moiety. Alternatively, X and Y may be concatenated to form a saccharyl or substituted saccharyl group. The compound 6 - [2 - (1 - aminocyclohexyl) - acetamido]- penicillanic acid has been prepared in two different crystalline forms both of which, together with their preparations, are described. As illustrations of the preparation of the starting compounds of Formula III, there are prepared: (a) 1-aminocyclohexane acetic acid by treating 1-azospiro[3,5]nonane-2-one with concentrated HCl (1-amino-2,6-trans-dimethylcyclohexane acetic acid hydrate; 1-aminocyclobutaneacetic acid; 2-(1-aminocyclooctyl)-2-methyl acetic acid 1-aminocyclooctaneacetic acid and 1- aminocycloheptane acetic acid being made similarly), (b) 1-aminocyclopentane acetic acid (and other similar acetic acid derivatives similarly) by reacting cyclopentanone with malonic acid and ammonium acetate (or with ammonium malonate) and, (e) the N-carboxy anhydrides of such acetic acid derivatives by treatment thereof with phosgene. Pharmaceutical compositions comprise the new penicillins of the invention in which Z is NH 2 in association or conjunction with conventional pharmaceutical carriers and excipients. They may be in forms suitable for oral, parenteral and topical administration.
priorityDate 1971-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID165593
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449831253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449353267
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12432
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458433570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451856157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453877548
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11309584
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419574899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448807426
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448868360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6410751
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158076308
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420127958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452986251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7057887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419515849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10290827
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158482037
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21899381
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21504672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID867
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453148806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455502157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474255
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6891

Total number of triples: 46.